Potential breakthrough cancer treatment entering clinical trials: ‘Great hopes’

Molecular oncology professor Dr. Linda Malkas and hematologist-oncologist Dr. Joseph Alvarnas discuss a potential cancer-killing drug named in honor of cancer patient Anna Healey.